Cours DexCom, Inc. Berne S.E.
Actions
DC4
US2521311074
Equipement, fournitures et distribution médicale
Cours en clôture
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
118,2 CHF | +7,35% | -.--% | -.--% |
CA 2024 * | 4,33 Md 3,86 Md | CA 2025 * | 5,15 Md 4,59 Md | Capitalisation | 46,11 Md 41,08 Md |
---|---|---|---|---|---|
Résultat net 2024 * | 728 M 649 M | Résultat net 2025 * | 906 M 807 M | VE / CA 2024 * | 11 x |
Dette nette 2024 * | 1,43 Md 1,28 Md | Dette nette 2025 * | 994 M 886 M | VE / CA 2025 * | 9,14 x |
PER 2024 * |
64,2
x | PER 2025 * |
52,5
x | Employés | 9 550 |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 96,62% |
Dernier transcript sur DexCom, Inc.
1 jour | +7,35% | ||
3 mois | +7,35% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Kevin Sayer
CEO | Chief Executive Officer | 66 | 01/11/07 |
Jereme Sylvain
DFI | Director of Finance/CFO | 44 | 01/09/18 |
Chief Tech/Sci/R&D Officer | 47 | 01/10/22 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Nick Augustinos
BRD | Director/Board Member | 65 | 20/11/09 |
Mark Foletta
BRD | Director/Board Member | 63 | 19/11/14 |
Eric Topol
BRD | Director/Board Member | 69 | 09/07/09 |
Nom | PEA | Position | Varia. 1 janv. | Notation |
---|---|---|---|---|
UBS(LUX)EF SUST HLTH TRNSFM $ P | Non | 7.9M USD | +2,00% | |
PRIVILEDGE AXA IM DSRPT INNOVTS USD MA | Non | 0.25M USD | +22,00% | |
HSBC GIF GLB EQ SUST HLTHCARE ACEUR | Non | 5.31M EUR | 0,00% | |
PSI POLAR CAPITAL FUT HLTHCR A USD ACC | Non | 7.12M USD | 0,00% | |
NEW CAPITAL HEALTHCARE DSRPTRS USD O ACC | Non | 4.43M USD | +5,00% |
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-5,81% | 180 Md | |
-1,63% | 106 Md | |
-4,14% | 67,55 Md | |
+13,22% | 45,79 Md | |
+2,58% | 41,61 Md | |
+19,93% | 31,07 Md | |
+11,40% | 24,77 Md | |
-5,36% | 24,27 Md | |
-11,92% | 22,05 Md |
- Bourse
- Actions
- Action DXCM
- Action DC4